Silence Therapeutics (SLNCF) Short Interest Ratio & Short Volume

$8.00
0.00 (0.00%)
(As of 05/3/2024 ET)

Silence Therapeutics Short Interest Data

Current Short Volume
600 shares
Previous Short Volume
0 shares
Change Vs. Previous Month
+∞
Dollar Volume Sold Short
$4,800.00
Short Interest Ratio / Days to Cover
0.7
Last Record Date
April 15, 2024
Today's Trading Volume
0 shares
Average Trading Volume
1,315 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Silence Therapeutics ?

Sign up to receive the latest short interest report for Silence Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SLNCF Short Interest Over Time

SLNCF Days to Cover Over Time

SLNCF Percentage of Float Shorted Over Time

Silence Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2024600 shares $4,800.00 No ChangeN/A0.7 $8.00
12/15/20223,600 shares $11,700.00 No ChangeN/A0 $3.25
2/15/2022300 shares $2,118.03 No ChangeN/A0.2 $7.06
12/15/2021500 shares $3,575.00 No ChangeN/A1.3 $7.15
7/30/2021100 shares $830.00 No ChangeN/A0.5 $8.30
7/15/2021100 shares $850.00 No ChangeN/A1 $8.50
6/30/2021100 shares $860.00 No ChangeN/A1 $8.60
6/15/2021100 shares $875.00 No ChangeN/A0.2 $8.75
1/29/2021200 shares $1,606.02 No ChangeN/A0.2 $8.03
1/15/2021500 shares $3,575.00 -16.7%N/A0.2 $7.15
12/31/2020500 shares $2,950.00 No ChangeN/A1.7 $5.90
12/15/2020500 shares $2,900.00 -16.7%N/A0.2 $5.80
11/30/2020600 shares $3,390.00 No ChangeN/A0.6 $5.65
11/15/2020600 shares $3,480.00 +50.0%N/A0.8 $5.80
10/30/2020400 shares $1,824.00 -87.5%N/A0.2 $4.56
10/15/20203,200 shares $15,840.00 +45.5%N/A1.7 $4.95
9/30/20202,200 shares $13,508.00 -4.4%N/A3.7 $6.14
9/15/20202,300 shares $14,122.00 -39.5%N/A0.5 $6.14
8/31/20203,800 shares $24,700.00 +52.0%N/A4.2 $6.50
8/14/20202,500 shares $0.00 -30.6%N/A4.2 $0.00

SLNCF Short Interest - Frequently Asked Questions

What is Silence Therapeutics' current short interest?

Short interest is the volume of Silence Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 600 shares of SLNCF short. Learn More on Silence Therapeutics' current short interest.

What is a good short interest ratio for Silence Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SLNCF shares currently have a short interest ratio of 1.0. Learn More on Silence Therapeutics's short interest ratio.

Is Silence Therapeutics' short interest increasing or decreasing?

Silence Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 600 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

What does it mean to sell short Silence Therapeutics stock?

Short selling SLNCF is an investing strategy that aims to generate trading profit from Silence Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Silence Therapeutics?

A short squeeze for Silence Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLNCF, which in turn drives the price of the stock up even further.

How often is Silence Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLNCF, twice per month. The most recent reporting period available is April, 15 2024.



More Short Interest Resources from MarketBeat

This page (OTCMKTS:SLNCF) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners